Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
51 trades · March 26, 2026 – September 1, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.
Showing the first 6 of 20 trades on this page.
Award disclosed
Akinbolade Oyegunwa
EVP, CIO & CTO
Restricted Stock Unit
Derivative security · not the ordinary share price.
Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Award disclosed
Jonathan C. Meltzer
EVP, COO
Restricted Stock Unit
Derivative security · not the ordinary share price.
Why this buying score?
No qualifying common-equity purchases
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
+0 pts
This score describes qualifying insider purchases at issuer level. Read the methodology
Sources and coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0000920148
Latest public acceptance
Sep 3, 2026, 12:21 PM UTC
Score calculated
Oct 6, 2026, 07:02 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Award disclosed
Bryan T. Vaughn
EVP and President, Diagnostics
Restricted Stock Unit
Derivative security · not the ordinary share price.
Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Award disclosed
Brian J. Caveney
EVP, Pres of BLS, CMO & CSO
Restricted Stock Unit
Derivative security · not the ordinary share price.
Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Sale disclosed
Kerrii B. Anderson
Director
Common Stock
Reported value
$954.06K
Reported price
$318.02 / share
Sale disclosed
Adam H. Schechter
President & CEO
Common Stock
Reported value
$1.5M
Reported price
$320.37 / share
Sale disclosed
Amy B. Summy
EVP, Chief Marketing Officer
Common Stock
Reported value
$283.43K
Reported price
$306.74 / share
Sale disclosed
Peter J. Wilkinson
SVP, Chief Accounting Officer
Common Stock
Reported value
$25.36K
Reported price
$309.22 / share
Exercise or conversion
Peter J. Wilkinson
SVP, Chief Accounting Officer
Common Stock
Value context
$279.98K
Reported price
$209.25 / share
Sale disclosed
Peter J. Wilkinson
SVP, Chief Accounting Officer
Common Stock
Reported value
$413.75K
Reported price
$309.2311 / share
Exercise or conversion
Peter J. Wilkinson
SVP, Chief Accounting Officer
Non-qualified Stock Options
Derivative security · not the ordinary share price.
Value context
Not a separate purchase
Exercise / conversion price
$209.25 exercise / conversion price
Understand this price
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Exercise or conversion
Kathryn W. Kyle
EVP, Chief Legal Officer
Common Stock
Value context
Unavailable
Reported price
Price not reported
Tax or exercise withholding
Kathryn W. Kyle
EVP, Chief Legal Officer
Common Stock
Value context
$20.72K
Reported price
$283.88 / share
Sale disclosed
Kathryn W. Kyle
EVP, Chief Legal Officer
Common Stock
Reported value
$26.33K
Reported price
$286.19 / share
Exercise or conversion
Kathryn W. Kyle
EVP, Chief Legal Officer
Restricted Stock Unit
Derivative security · not the ordinary share price.
Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Exercise or conversion
Bryan T. Vaughn
EVP and President, Diagnostics
Common Stock
Value context
Unavailable
Reported price
Price not reported
Tax or exercise withholding
Bryan T. Vaughn
EVP and President, Diagnostics
Common Stock
Value context
$26.4K
Reported price
$283.88 / share
Sale disclosed
Bryan T. Vaughn
EVP and President, Diagnostics
Common Stock
Reported value
$66.97K
Reported price
$286.19 / share
Exercise or conversion
Bryan T. Vaughn
EVP and President, Diagnostics
Restricted Stock Unit
Derivative security · not the ordinary share price.
Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.